Condensed Consolidated Statements of Operations and Comprehensive Earnings and Loss (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 30,239	$ 32,046	$ 88,498	$ 91,603
Less provision for bad debts of Healthcare Facilities Segment	2,521	2,806	8,138	8,823
Net revenues	27,718	29,240	80,360	82,780
Costs and Expenses
Cost of goods sold	7,078	7,319	17,838	18,085
Salaries, wages and benefits	12,537	13,287	38,292	39,894
Provision for bad debts of Specialty Pharmacy Segment	75	129	170	386
Supplies	2,058	2,213	6,553	6,913
Purchased services	1,850	1,777	5,608	5,629
Other operating expenses	3,789	3,218	11,194	11,299
Rent and lease expense	462	450	1,381	1,454
Impairment of property, plant and equipment	0	0	0	789
EHR incentive payments	(43)	93	(1,341)	(931)
Depreciation and amortization	910	1,022	2,715	2,995
Operating Loss	(998)	(268)	(2,050)	(3,733)
Other Expense:
Interest expense - net	(303)	(300)	(922)	(1,506)
Gain on sale of assets	18	0	18	0
Loss from Continuing Operations before income taxes	(1,283)	(568)	(2,954)	(5,239)
Income Tax Benefit	(372)	(371)	(856)	(2,025)
Loss from Continuing Operations	(911)	(197)	(2,098)	(3,214)
Earnings (loss) from Discontinued Operations, net of tax	(53)	11	203	5,539
Net Earnings (Loss)	(964)	(186)	(1,895)	2,325
Other comprehensive income	0	0	0	0
Comprehensive Earnings (Loss)	$ (964)	$ (186)	$ (1,895)	$ 2,325
Continuing Operations:
Basic	$ (0.10)	$ (0.02)	$ (0.22)	$ (0.34)
Diluted	$ (0.10)	$ (0.02)	$ (0.22)	$ (0.34)
Discontinued Operations:
Basic	$ (0.01)	$ 0.00	$ 0.02	$ 0.59
Diluted	$ (0.01)	$ 0.00	$ 0.02	$ 0.59
Net Earnings (Loss):
Basic	$ (0.10)	$ (0.02)	$ (0.20)	$ 0.25
Diluted	$ (0.10)	$ (0.02)	$ (0.20)	$ 0.25
Weighted-Average Common Shares Outstanding:
Basic	9,443	9,446	9,443	9,446
Diluted	9,443	9,446	9,443	9,446